Dataset from Zenodo · Sirsat, Nitin
Global Dry Eye Syndrome Treatment Market 2024 To 2033
- License
- CC BY 4.0commercial use allowedLicense text
- This license allows commercial use. Usually you must credit the author; read the license for the exact terms.
- Formats
- CSV
- Size
- 665 byte
- Updated
- Jan 3, 2025
Description
Dry Eye Syndrome Treatment Market Size, Trends and Insights By Type (Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome), By Drug (Restasis, Xiidra, Cequa, Eysuvis, Tyrvaya, Others), By Product (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements, Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments, Others), By Sales Channel (Prescription, OTC), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033. Reports Description As per the current market research conducted by the CMI Team, the global Dry Eye Syndrome Treatment Market is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 6,605.8 Million . By 2033, the valuation is anticipated to reach USD 12,281.4 Million . The dry eye syndrome treatment market encompasses pharmaceuticals, devices, and therapies aimed at alleviating symptoms and addressing the underlying causes of dry eye. With a growing global prevalence…
Description from Zenodo, shortened.
Files (1)
DataHunter does not store or host these files: every link leads to the original source. Check the license there before using the data.